PDE1B
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
Also known as: PDE1B_HUMAN, PDES1B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01064
- Gene
- PDE1B
- Ensembl
- ENSG00000123360
- Chromosome
- 12
- Canonical length
- 536 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the cyclic nucleotide phosphodiesterase (PDE) family, and PDE1 subfamily. Members of the PDE1 family are calmodulin-dependent PDEs that are stimulated by a calcium-calmodulin complex. This PDE has dual-specificity for the second messengers, cAMP and cGMP, with a preference for cGMP as a substrate. cAMP and cGMP function as key regulators of many important physiological processes. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jul 2011]
Canonical amino-acid sequenceUniProt
536 residues, UniProt reviewed canonical sequence.
>Q01064|PDE1B
1 MELSPRSPPE MLEESDCPSP LELKSAPSKK MWIKLRSLLR YMVKQLENGE INIEELKKNL
61 EYTASLLEAV YIDETRQILD TEDELQELRS DAVPSEVRDW LASTFTQQAR AKGRRAEEKP
121 KFRSIVHAVQ AGIFVERMFR RTYTSVGPTY STAVLNCLKN LDLWCFDVFS LNQAADDHAL
181 RTIVFELLTR HNLISRFKIP TVFLMSFLDA LETGYGKYKN PYHNQIHAAD VTQTVHCFLL
241 RTGMVHCLSE IELLAIIFAA AIHDYEHTGT TNSFHIQTKS ECAIVYNDRS VLENHHISSV
301 FRLMQDDEMN IFINLTKDEF VELRALVIEM VLATDMSCHF QQVKTMKTAL QQLERIDKPK
361 ALSLLLHAAD ISHPTKQWLV HSRWTKALME EFFRQGDKEA ELGLPFSPLC DRTSTLVAQS
421 QIGFIDFIVE PTFSVLTDVA EKSVQPLADE DSKSKNQPSF QWRQPSLDVE VGDPNPDVVS
481 FRSTWVKRIQ ENKQKWKERA ASGITNQMSI DELSPCEEEA PPSPAEDEHN QNGNLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 96 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 96 nTPM
- cerebral cortex: 31 nTPM
- urinary bladder: 12 nTPM
- colon: 11 nTPM
- blood vessel: 11 nTPM
- adipose tissue: 10 nTPM
Single-cell type
- brain inhibitory neurons: 102 nCPM
- kupffer cells: 34 nCPM
- neutrophils: 32 nCPM
- vascular smooth muscle cells: 24 nCPM
- pericytes: 24 nCPM
- hofbauer cells: 24 nCPM
Immune cell
- naive CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 193 nTPM
- cerebral cortex: 60 nTPM
- white matter: 44 nTPM
- amygdala: 36 nTPM
- thalamus: 27 nTPM
- hippocampal formation: 25 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 2.27
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to granulocyte macrophage colony-stimulating factor stimulus
- cellular response to macrophage colony-stimulating factor stimulus
- dopamine catabolic process
- locomotory behavior
- monocyte differentiation
- negative regulation of cAMP/PKA signal transduction
- response to amphetamine
- serotonin metabolic process
- signal transduction
- visual learning
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- calmodulin binding
- calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity
- calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
- HD/PDEase domain
- PDE1, N-terminal domain
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase, conserved site
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase N-terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE1B as an antibody target. Whether an autoantibody or antibody against PDE1B could matter depends on whether native PDE1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDE1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...